Prosecution Insights
Last updated: October 02, 2026
Application No. 18/291,294

STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE

Final Rejection §112
Filed
Jan 23, 2024
Priority
Aug 19, 2021 — provisional 63/234,935 +1 more
Examiner
BAKSHI, PANCHAM
Art Unit
Tech Center
Assignee
Amgen Inc.
OA Round
2 (Final)
77%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
898 granted / 1169 resolved
+16.8% vs TC avg
Strong +30% interview lift
Without
With
+30.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
74 currently pending
Career history
1229
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
30.9%
-9.1% vs TC avg
§102
19.9%
-20.1% vs TC avg
§112
29.8%
-10.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1169 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Application Claims 1-4, 6-36 are pending and under current examination. Amendment necessitated new claim rejection as set forth below. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-4, 6-33 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claims 1-4, 6-33 are indefinite as: Claim 1 recites “low temperature”, wherein “low” is a relative term and renders the claim indefinite. This is because said term is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim 3 recites “low temperature”, wherein “low” is a relative term and renders the claim indefinite. This is because said term is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim 33 recites “low temperature”, wherein “low” is a relative term and renders the claim indefinite. This is because said term is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Appropriate correction required. Since the dependent claims 2-4 and 6-33 doesn’t cure the above deficiencies, these claims are also indefinite. Citation of Relevant Prior art The prior art made of record and not relied upon is considered pertinent to applicant’s disclosure. Following is the relevance of the prior art made of record: US 20120189546 A1: The prior art teaches a method of preparing compound 2 from compound 3; compound 3 from compound 4; and compound 4 from compound 5 as in the instant claims with a difference that the cited prior art method of purification of compound 2 is different (involves triple distillation) from the instant claims and does not involve formation of salt by treatment with base followed by treatment with acid. Further, the cited prior art does not teach trifluoroalkylation of compound 2 to form compound 1. Bugera (JOC; 2019, 84; 16105-16115): teaches a method of making (1) from compound 2 as in the instant claims with a difference that process of Bugera uses water instead of organic solvent of the instant claims. Kautzky (JACS; 2018, 140, 6522-6526)-teaches a method of making compound similar to 1 (different with respect to ring size, halogen substitution and optical activity) from starting compound similar to 2 (different with respect to ring size, halogen substitution and optical activity) using trifluoromethylating agent in organic solvent as in the instant claims. Allowable Subject Matter Claims 34-36 presents allowable subject matter over the cited prior art. Objection Claims 34-36 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Response to Arguments Applicants’ remarks and amendments, filed on 09/09/2026, have been fully considered but not found persuasive. Applicants argue that the “claim language employing terms of degree---- enough certainty to one of ordinary scale in the art when read in the context of the invention”. This is not found persuasive as in the instant claims the terms of degree does not have enough certainty to one of ordinary scale in the art when read in the context of the invention. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Conclusion No Claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PANCHAM BAKSHI whose telephone number is (571)270-3463. The examiner can normally be reached M-Thu 7-4.30 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Milligan Adam can be reached at 571-2707674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PANCHAM BAKSHI/Primary Examiner, Art Unit 1623
Read full office action

Prosecution Timeline

Jan 23, 2024
Application Filed
Mar 18, 2025
Response after Non-Final Action
Jun 10, 2026
Non-Final Rejection mailed — §112
Sep 09, 2026
Response Filed
Sep 23, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741978
ZINC COMPOUND, THIN-FILM FORMING RAW MATERIAL, THIN-FILM, AND METHOD OF PRODUCING THIN-FILM
3y 12m to grant Granted Sep 22, 2026
Patent 12741919
METHOD AND DEVICE FOR THE PHOTOINDUCED CONVERSION OF CO2 TO METHANOL
3y 3m to grant Granted Sep 22, 2026
Patent 12741921
PROCESS FOR THE PRODUCTION OF ETHYL TERTIARY BUTYL ETHERS
3y 2m to grant Granted Sep 22, 2026
Patent 12734150
COMPOSITIONS AND METHODS FOR INCREASING T CELL FUNCTION
4y 11m to grant Granted Sep 15, 2026
Patent 12735387
SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES
4y 1m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
77%
Grant Probability
99%
With Interview (+30.2%)
2y 3m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1169 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month